Webinar on


January 27, 2022

Oncology Webinar

Theme: Amalgamation of innovations in cancer treatment & Challenges during COVID-19

We welcome all the dynamic scholars from around the globe to join at Webinar on Oncology. The summit will move forward with the theme Amalgamation of Innovations in Cancer Treatment & Challenges During Covid-19 which will pile up oncologists, oncology skilled, oncology students, oncology researchers, oncology educators,  oncology business leaders etc.
In Oncology 2022, we have a tendency to take a more in-depth look into some superb trends that are set to alter the Oncology care for good. It provides a good chance for establishing robust relations between the oncology organizations, the final public and government in order that they can work together  to achieve a good health and happier lives. The field of Oncology is growing rapidly and its development is making tremendous impacts in cancer care. The importance and significance can be evaluated by the fact that it has made huge advancements over the course of time and is continuing to influence various Interdisciplinary sectors.
Session 1: Oncology
The study of cancer is a much known firm with emerging inventions patenting in order to cure as well as prevent people from the risk of cancer. Since now, more than 120 types of cancer have been reported. Apart from more common cancers, rare cancers like Ataxia-Telangiectasia, Familial GIST are also affecting peoples in various parts of the world.
In the elimination phase, the immune response leads to destruction of tumor cells and therefore to tumor suppression. However, some tumor cells may gain more mutations, change their characteristics and evade the immune system. These cells might enter the equilibrium phase, in which the immune system doesn’t recognise all tumor cells, but at the same time the tumor doesn’t grow. 
As per the UICC report, around 8 million people are dying worldwide because of cancer. One in three of us will develop cancer at some time in our lives, and one in four will die of it. As we see locally, cancer is now the most common cause of premature death in Scotland. Each year, around 29,000 people will have a new cancer diagnosed and at any one time around 150,000 people may be affected. This number will be increasing towards the end of the century due to the increase in the elderly population.
Session 4: Women Cancer
Some of the cancers that most often affect women are breast, colorectal, endometrial, lung, cervical, skin, and ovarian cancers. Knowing about these cancers and what you can do to help prevent them or find them early (when they are small, haven't spread, and might be easier to treat) may help save your life.
Session 5: Medical Oncology
Medical oncology is a method of treating cancer by using principles of Chemotherapy, Immunotherapy, Hormonal therapy and targeted therapy in a sufficient way to treat cancer. In order to get effective positive outcomes, medical oncology is used in conjunction with surgical oncology and radiation oncology. Oncology 2022 will give you the ideas about developing these techniques which could melt down the certain hurdles in diagnostics and treatment.

For the past 25 years Oncology has kept pace with the progression of the oncology field and has offered an interpretation of literature which appeals to both the academician and the practicing "in-the-trenches" community oncologist.

Editorial features such as Practice & Policy, explore the changing times in the healthcare landscape in such areas as FDA regulations, Medicare & Medicaid policy, and the impact of health care reform. Another feature is Integrative Oncology which covers alternative herbal treatments, uses, research, adverse reactions and interactions. Oncology  serves as a strong resource and forum for the cancer care clinician and generates a strong sense of community among its readers.

  • Oncology
  • Tumour Immunology and Immunotherapy
  • Oncology diagnostics & Therapeutics
  • Women Cancer
  • Medical Oncology

Media Partners & Collaborations

Media Partner

Media Partner

Media Partner

Media Partner